Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DECONGESTION NASAL SPRAY HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
3.2.2. OVER THE COUNTER PRESCRIPTION IS ANTICIPATED TO GROW SIGNIFICANTLY
3.2.3. ANTIHISTAMINE IS THE FASTEST GROWING THERAPEUTICS
3.2.4. NASAL CONGESTION IS THE MAJORLY USED APPLICATION OF NASAL SPRAY DEVICES
3.2.5. HOME CARE SETTING IS THE FASTEST GROWING END-USER

4. MARKET DETERMINANTS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. SURGE IN INCIDENCE OF RESPIRATORY DISEASES
4.2.2. LOW COST OF GENERIC PRESCRIPTION DRUGS
4.3. MARKET RESTRAINTS
4.3.1. STRINGENT REGULATION
4.3.2. RISING INCIDENCES OF PRODUCT RECALL
4.4. MARKET OPPORTUNITIES
4.4.1. RISING ADOPTION OF GENERIC DRUGS
4.4.2. GROWING DEMAND OF NASAL DRUGS IN PHARMACEUTICAL MARKET
4.5. MARKET CHALLENGES
4.5.1. PATENT EXPIRATION

5. MARKET BY PRODUCT
5.1. DECONGESTION NASAL SPRAY
5.2. SALTWATER SOLUTION/SALINE NASAL SPRAY
5.3. STEROID NASAL SPRAY

6. MARKET BY PRESCRIPTION
6.1. OVER-THE-COUNTER
6.2. PRESCRIBED

7. MARKET BY THERAPEUTIC
7.1. ANTIHISTAMINE
7.2. ANTICHOLINERGIC
7.3. MAST CELL INHIBITOR
7.4. NASAL STEROIDS

8. MARKET BY APPLICATION
8.1. ALLERGIC AND NON-ALLERGIC RHINITIS
8.2. CNS DISORDERS
8.3. NASAL CONGESTION
8.4. VACCINATION
8.5. OTHER APPLICATION

9. MARKET BY END-USER
9.1. ASC/CLINICS
9.2. HOME CARE SETTING
9.3. HOSPITAL
9.4. PHARMACY
9.5. OTHER END-USER

10. KEY ANALYTICS
10.1. PORTER’S FIVE FORCES MODEL
10.1.1. THREAT OF NEW ENTRANTS
10.1.2. THREAT OF SUBSTITUTE
10.1.3. BARGAINING POWER OF BUYERS
10.1.4. BARGAINING POWER OF SUPPLIERS
10.1.5. THREAT OF COMPETITIVE RIVALRY
10.2. KEY BUYING CRITERIA
10.3. SUPPLY CHAIN ANALYSIS
10.4. REGULATORY FRAMEWORK
10.5. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS
11.1. ASIA PACIFIC
11.1.1. CHINA
11.1.2. INDIA
11.1.3. JAPAN
11.1.4. AUSTRALIA
11.1.5. SOUTH KOREA
11.1.6. REST OF ASIA PACIFIC

12. COMPETITIVE LANDSCAPE
12.1. MARKET SHARE ANALYSIS
12.2. COMPANY PROFILES
12.2.1. ADAPT PHARMA, INC. (ACQUIRED BY EMERGENT BIOSOLUTIONS)
12.2.1.1. COMPANY OVERVIEW
12.2.1.2. PRODUCT LAUNCH
12.2.1.3. STRATEGIC INITIATIVES
12.2.2. ALLERGAN INC.
12.2.2.1. COMPANY OVERVIEW
12.2.2.2. PRODUCT & SERVICES
12.2.2.3. SCOT ANALYSIS
12.2.2.4. STRATEGIC INITIATIVES
12.2.3. APOTEX
12.2.3.1. COMPANY OVERVIEW
12.2.3.2. PRODUCT PORTFOLIO
12.2.3.3. STRATEGIC INITIATIVES
12.2.4. BECTON DICKINSON AND COMPANY
12.2.4.1. COMPANY OVERVIEW
12.2.4.2. PRODUCT PORTFOLIO
12.2.4.3. SCOT ANALYSIS
12.2.4.4. STRATEGIC INITIATIVES
12.2.5. BEXIMCO PHARMACEUTICALS
12.2.5.1. COMPANY OVERVIEW
12.2.5.2. PRODUCT LAUNCH
12.2.5.3. STRATEGIC INITIATIVES
12.2.6. CIPLA
12.2.6.1. COMPANY OVERVIEW
12.2.6.2. PRODUCT PORTFOLIO
12.2.6.3. SCOT ANALYSIS
12.2.6.4. STRATEGIC INITIATIVES
12.2.7. GLAXOSMITHKLINE
12.2.7.1. COMPANY OVERVIEW
12.2.7.2. PRODUCT PORTFOLIO
12.2.7.3. SCOT ANALYSIS
12.2.7.4. STRATEGIC INITIATIVES
12.2.8. HIKMA PHARMACEUTICALS PLC
12.2.8.1. COMPANY OVERVIEW
12.2.8.2. PRODUCT PORTFOLIO
12.2.8.3. STRATEGIC INITIATIVES
12.2.9. MERCK & CO., INC.
12.2.9.1. COMPANY PROFILES
12.2.9.2. PRODUCT PORTFOLIO
12.2.9.3. SCOT ANALYSIS
12.2.9.4. STRATEGIC INITIATIVES
12.2.10. MYLAN NV
12.2.10.1. COMPANY OVERVIEW
12.2.10.2. PRODUCT PORTFOLIO
12.2.10.3. STRATEGIC INITIATIVES
12.2.11. PFIZER, INC.
12.2.11.1. COMPANY PROFILES
12.2.11.2. PRODUCT PORTFOLIO
12.2.11.3. SCOT ANALYSIS
12.2.11.4. STRATEGIC INITIATIVES
12.2.12. SANDOZ INTERNATIONAL GMBH (SUBSIDIARY OF NOVARTIS AG)
12.2.12.1. COMPANY OVERVIEW
12.2.12.2. PRODUCT PORTFOLIO
12.2.12.3. STRATEGIC INITIATIVES
12.2.13. SANOFI-AVENTIS S.A.
12.2.13.1. COMPANY OVERVIEW
12.2.13.2. PRODUCT PORTFOLIO
12.2.13.3. SCOT ANALYSIS
12.2.13.4. STRATEGIC INITIATIVES
12.2.14. SUN PHARMACEUTICALS INDUSTRIES, LTD.
12.2.14.1. COMPANY OVERVIEW
12.2.14.2. PRODUCT PORTFOLIO
12.2.14.3. SCOT ANALYSIS
12.2.14.4. STRATEGIC INITIATIVE
12.2.15. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.2.15.1. COMPANY OVERVIEW
12.2.15.2. PRODUCT PORTFOLIO
12.2.15.3. STRATEGIC INITIATIVES

TABLE LIST
TABLE 1 ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC DECONGESTION NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC STEROID NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC OVER THE COUNTER MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC PRESCRIBED MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC ANTIHISTAMINE MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC ANTICHOLINERGIC MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC MAST CELL INHIBITOR MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC NASAL STEROIDS MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC ALLERGIC AND NON-ALLERGIC RHINITIS MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC CNS DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC NASAL CONGESTION MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC VACCINATION MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC ASC/CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC HOME CARE SETTING MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC PHARMACY MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 26 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)


FIGURES LIST
FIGURE 1 ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)
FIGURE 7 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
FIGURE 10 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 21 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 26 PORTER’S FIVE FORCE MODEL
FIGURE 27 KEY BUYING CRITERIA
FIGURE 28 ASIA PACIFIC NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS
FIGURE 29 ASIA PACIFIC NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 30 CHINA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 31 INDIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 JAPAN NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 33 AUSTRALIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 34 SOUTH KOREA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 36 NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)



List of Figures


FIGURES LIST
FIGURE 1 ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)
FIGURE 7 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
FIGURE 10 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 21 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 26 PORTER’S FIVE FORCE MODEL
FIGURE 27 KEY BUYING CRITERIA
FIGURE 28 ASIA PACIFIC NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS
FIGURE 29 ASIA PACIFIC NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 30 CHINA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 31 INDIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 JAPAN NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 33 AUSTRALIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 34 SOUTH KOREA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 36 NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)

 

List of Tables


TABLE LIST
TABLE 1 ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC DECONGESTION NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC STEROID NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC OVER THE COUNTER MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC PRESCRIBED MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC ANTIHISTAMINE MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC ANTICHOLINERGIC MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC MAST CELL INHIBITOR MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC NASAL STEROIDS MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC ALLERGIC AND NON-ALLERGIC RHINITIS MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC CNS DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC NASAL CONGESTION MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC VACCINATION MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC ASC/CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC HOME CARE SETTING MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC PHARMACY MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 26 ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)